| Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273) |
|---|
| 03/17/2005 | WO2005023960A1 Electroluminescent device |
| 03/17/2005 | WO2005023794A2 Compound libraries of 4-carboxamidopiperidine derivatives |
| 03/17/2005 | WO2005023771A1 Chemokine receptor antagonist and medical use thereof |
| 03/17/2005 | WO2005023770A1 Salicylic acid derivatives, process for production thereof and disease controllers for agricultural and horticultural use |
| 03/17/2005 | WO2005023765A1 Method for catalyzing amidation reactions by the presence of co2 |
| 03/17/2005 | WO2005023422A2 Production and use of ionic liquids containing thiocyanato anions |
| 03/17/2005 | WO2005023261A1 1-benzoyl-piperazine derivatives as glycine uptake inhibitors for the treatment of psychoses |
| 03/17/2005 | WO2005023204A2 Aromatic prodrugs of propofol, compositions and uses thereof |
| 03/17/2005 | WO2005000817A3 Diphenylpyridine derivatives, preparation and therapeutic application thereof |
| 03/17/2005 | WO2004111008A3 Use of a compound of formula i for making a pharmaceutical composition |
| 03/17/2005 | WO2004106939A3 Method for the linkage of bifunctional chelating agents and (radioactive) transition metal complexes to proteins and peptides |
| 03/17/2005 | WO2004104014A3 Chiral ligands and their transition metal complexes |
| 03/17/2005 | US20050059824 Using carbon dioxide; salt formation, hydrolysis |
| 03/17/2005 | US20050059810 Dibenzylamine compound and medicinal use thereof |
| 03/17/2005 | US20050059786 Process for the co-oligomerisation of ethylene and alpha olefins |
| 03/17/2005 | US20050059729 Substituted cyclic compounds |
| 03/17/2005 | US20050059714 2-Cyclopropyl-4-(5-fluoro-2-methoxyphenyl)-4-methyl-1-(1H-pyrrolo[2,3-c]pyridin-2-yl)pentan-2-ol; treating diseases of inflammatory, allergic, or proliferative condition; type II diabetes, obesity, cardiovascular diseases, hypertension, arteriosclerosis, neurological diseases, adrenal and pituitary tumor |
| 03/17/2005 | US20050059712 Immunosuppressants for treating skin disorders, acne, alopecia, estrogen- or androgen-dependent tumors, rheumatoid arthritis, type I and II diabetes, lupus erythematosus, multiple sclerosis, ulcerative colitis, Crohn's disease, psoriasis, contact dermatitis, graft versus host disease, eczema, asthma |
| 03/17/2005 | US20050059710 Diphenylamino ketone derivatives as MEK inhibitors |
| 03/17/2005 | US20050059708 Chemical intermediates of pioglitazone, rosiglitazone and troglitazone; starting inexpensive material, especially tyrosine; hypoglycemic agents, antidiabetic agent, antilipemic agents |
| 03/17/2005 | US20050059707 Benzoyl-, indanoyl- or tetrahydronaphthoyl-oxy (or thio) nicotinic acid derivatives; a kit comprising two chambers for mixing the compound in solid form with a topical carrier within seven days prior to topical administration |
| 03/17/2005 | US20050059668 Substituted acylpiperazine derivatives |
| 03/17/2005 | CA2538135A1 1-benzoyl-piperazine derivatives as glycine uptake inhibitors for the treatment of psychoses |
| 03/16/2005 | EP1514559A1 Arylpiperazines having activity at the serotonin 1a receptor |
| 03/16/2005 | EP1513917A1 Use of transition metal complexes with nitrogen-containing polydentate ligands as a bleaching catalyst and bleaching agent composition |
| 03/16/2005 | EP1513911A1 Phosphorescent and luminescent conjugated polymers and their use in electroluminescent assemblies |
| 03/16/2005 | EP1513810A1 4-(aryl or heteroaryl) -2-butylamine derivatives and their use as glucocorticoid ligans |
| 03/16/2005 | EP1513802A1 Alpha-sulfonylamino-acetonitriles |
| 03/16/2005 | EP1513795A2 Propionic acid derivatives and their use as hppars activators |
| 03/16/2005 | EP1513526A1 Phenylalkanoic acid and phenyloxyalkanoic acid derivatives as hppar activators |
| 03/16/2005 | EP1311476B1 Aza-amino acid derivatives (factor x a?-inhibitors 15) |
| 03/16/2005 | EP1250047B1 Herbicidal composition |
| 03/16/2005 | EP1215200B1 Aromatic diamide derivatives or salts thereof, agricultural/horticultural chemicals and method of using the same |
| 03/16/2005 | EP1135134B1 Use of neurotrophic factor stimulators for the treatment of ophthalmic neurodegenerative diseases |
| 03/16/2005 | EP1049664B1 Inhibition of raf kinase using symmetrical and unsymmetrical substituted diphenyl ureas |
| 03/16/2005 | EP0874625B1 Indane derivatives for antipsychotic compositions |
| 03/16/2005 | CN1596251A Piperazine derivatives having SST1 antagonistic activity |
| 03/16/2005 | CN1596240A Chalcone derivatives and their use to treat diseases |
| 03/16/2005 | CN1594294A Cyanoacrylate compounds containing fluoro pyridine-methylamino group and their bioactivity |
| 03/16/2005 | CN1193015C Non-symmetrical ligands and catalyst systems thereof for ehtylene oligomerisation to linear alpha olefins |
| 03/16/2005 | CN1193010C Heterocyclonitrogen heteroethane derivant with antiviral activity |
| 03/16/2005 | CN1193000C Biphenyl derivatives substituted by an aromatic or heteroaromatic radical and pharmaceutical and cometic compositions containing same |
| 03/15/2005 | US6867310 Synthesize efficiently and under mild conditions alpha -aryl and alpha -vinyl products from a wide range of starting materials, including ketones, esters, hydrazones, and imines, enantiomorphs |
| 03/15/2005 | US6867298 Group IB compounds used as condensation, amination, amidation or arylation catalysts; catalysis; efficiency |
| 03/15/2005 | US6867221 Cyclic amine compounds and pharmaceutical composition containing the same |
| 03/15/2005 | US6867218 An arylene or heteroarylene alkoxy or hydroxy-propionic acid or ester derivatives; treatment or prevention of Peroxisome Proliferator-Activated Receptors; diabetes, impaired glucose tolerance, insulin resistance or obesity |
| 03/15/2005 | US6867217 Substituted polycyclic aryl and heteroaryl pyridones useful for selective inhibition of the coagulation cascade |
| 03/15/2005 | US6867215 Cardioprotective phosphonates and malonates |
| 03/15/2005 | US6867210 For treatment or prevention of neurodegenerative conditions such as amyotrophic lateral sclerosis, acute or chronic pain, as antitinnitus agents, anticonvulsants, antimanic depressants, local anesthetics, antiarrhythmics |
| 03/15/2005 | US6867205 Useful for the treatment and/or prophylaxis of diseases associated with dipeptidyl peptidase, such as diabetes, particularly non-insulin dependent diabetes mellitus, and impaired glucose tolerance |
| 03/15/2005 | US6867203 Cinnamide derivatives with aryl sulfide functionality; cerebral vasospasm |
| 03/15/2005 | CA2279779C Process for preparation of substituted 3-hydroxypiperidines |
| 03/15/2005 | CA2085785C The use of 4-aminopyridine in the treatment of a neurological condition |
| 03/10/2005 | WO2005022962A1 Compound, charge transport material and organic electroluminescent device |
| 03/10/2005 | WO2005021553A1 Naphthalene carboxamides and their derivatives useful as new anti-angiogenic agents |
| 03/10/2005 | WO2005021536A2 Adamantane and azabicyclo-octane and nonane derivatives, process of their preparation and their use as dpp-iv inhibitors |
| 03/10/2005 | WO2005021529A1 Bipyridyl amines and ethers as modulators of metabotropic glutamate receptor-5 |
| 03/10/2005 | WO2005021523A1 Piperazine substituted compounds used as calcium channel blockers |
| 03/10/2005 | WO2005021522A1 Synthesis of 1-‘4-(2-methoxyphenyl) piperazin-1-yl !-3-(2,6-dioxopiperidin-1-yl) propane |
| 03/10/2005 | WO2005021521A1 Preparation of 1-[4-(2-methoxy-phenyl)-piperazin-1-yl]-3-(2,6-dioxopiperidin-1-yl) propane hydrochloride |
| 03/10/2005 | WO2005021508A1 Phenyl or pyridyl amide compounds as prostaglandin e2 antagonists |
| 03/10/2005 | WO2005021490A2 N-SULFONYL-α-AMINO-ACID DERIVATIVES |
| 03/10/2005 | WO2005021488A1 Insecticide for agricultural or horticultural use and method of use thereof |
| 03/10/2005 | WO2005021486A1 Ester derivative and medicinal use thereof |
| 03/10/2005 | WO2005020899A2 Substituted cycloalkyamine derivatives as modulators of chemokine receptor activity |
| 03/10/2005 | WO2005020897A2 Compositions and methods for the treatment of disease associated with trp-p8 expression |
| 03/10/2005 | WO2005000109A3 Quaternary nitrogen heterocyclic compounds for detecting aqueous monosaccharides in physiological fluids |
| 03/10/2005 | WO2004103278A3 Acyl sulfonamides as inhibitors of hiv integrase |
| 03/10/2005 | WO2004099148A8 Substituted pyrimidine derivatives |
| 03/10/2005 | WO2004096795A3 C-fms kinase inhibitors |
| 03/10/2005 | WO2004041802A8 4(phenyl-piperazinyl-methyl) benzamide derivatives and their use for the treatment of pain or gastrointestinal disorders |
| 03/10/2005 | US20050054849 Coordination sites of four nitrogen-containing groups of of imino, amido and amino groups, and has the nitrogen atoms of the four nitrogen-containing groups as coordinating atoms in one plane; metal complex assembly; acceptor and a donor interacting with each other; nanostructure; semiconductors |
| 03/10/2005 | US20050054819 Such as 1-benzylcyclobutyl (1S)-1-(oxo{[(1R)-1-phenylethyl]amino}acetyl)pentylcarbamate for treatment of osteoporosis |
| 03/10/2005 | US20050054715 Vinyl phenyl derivatives as glk activators |
| 03/10/2005 | US20050054692 secondary carbocyclic amides such as N-(4-methylcyclohexyl)-2-(4-pyridylmethyl)amino)benzoic acid amide, used as tyrosine kinase inhibitors, for treating diseases caused by persistent angiogenesis |
| 03/10/2005 | US20050054690 Phenacyl 2-hydroxy-3-diaminoalkanes |
| 03/10/2005 | US20050054654 VEGFR-2 and VEGFR-3 inhibitory anthranilamide pyridines |
| 03/10/2005 | US20050054651 Compositions and methods for the treatment of disease associated with Trp-p8 expression |
| 03/10/2005 | US20050054637 Prophylaxis, therapy cardiovascular disorders |
| 03/10/2005 | US20050054626 Substituted cycloalkylamine derivatives as modulators of chemokine receptor activity |
| 03/10/2005 | US20050054582 Para-amino benzoic acids as integrin antagonists |
| 03/10/2005 | CA2772017A1 Agricultural/horticultural insecticide and method for using the same |
| 03/10/2005 | CA2537487A1 Piperazine substituted compounds used as calcium channel blockers |
| 03/10/2005 | CA2537141A1 Bipyridyl amines and ethers as modulators of metabotropic glutamate receptor-5 |
| 03/10/2005 | CA2537123A1 New compounds |
| 03/10/2005 | CA2536788A1 Naphthalene carboxamides and their derivatives useful as new anti-angiogenic agents |
| 03/10/2005 | CA2535265A1 Compositions and methods for the treatment of disease associated with trp-p8 expression |
| 03/09/2005 | EP1512460A1 Preparation and use of ionic liquids having thiocyanat as anion |
| 03/09/2005 | EP1512402A1 Inhibitors against complex ii of electron transport system |
| 03/09/2005 | EP1512397A1 O-substituted hydroxyaryl derivatives |
| 03/09/2005 | EP1511731A1 Method for producing 4-haloalkyl nicotinic acid amides |
| 03/09/2005 | EP1511730A2 Diaryl urea derivatives useful for the treatment of protein kinase dependent diseases |
| 03/09/2005 | EP1511713A2 Compounds that abrogate dna-damage-induced cell cycle g2 checkpoint and/or augment the anti-cancer activity of dna-damaging treatments |
| 03/09/2005 | EP1511710A1 Compounds, compositions and methods for the treatment of amyloid diseases and synucleinopathies such as alzheimer s disease, type 2 diabetes, and parkinson s disease |
| 03/09/2005 | EP1511488A2 Human adam-10 inhibitors |
| 03/09/2005 | EP1432685B1 Crystalline hydrates of anilid derivatives as fungicides and insecticides |
| 03/09/2005 | EP1123918B1 Aromatic amine derivatives, process for the preparation thereof and agents containing the same |
| 03/09/2005 | CN1592743A Inhibitors of glycogen synthase kinase 3 |
| 03/09/2005 | CN1592741A Antiretroviral pyridine and quinoline derivatives |
| 03/09/2005 | CN1592735A Novel alpha-oxygenated or alpha-thiolated carboxylic acid phenethylamide derivatives |